Patent details
EP3565586 Title: EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF
Basic Information
- Publication number:
- EP3565586
- PCT Application Number:
- US2018012610
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187046396
- PCT Publication Number:
- WO2018129336
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF
- French Title of Invention:
- PROCEDE D'EXPANSION POUR LA PROPAGATION DES LYMPHOCYTES INFILTRANT LES TUMEURS AVEC DES AGONISTES DES CANAUX POTASSIQUES ET LEURS UTILISATIONS THERAPEUTIQUES
- German Title of Invention:
- METHODE ZUR VERMEHRUNG VON TUMORINFLITRIERENDEN LYMPHOZYTEN MIT KALIUMKANALAGONISTEN UND THERAPEUTISCHE VERWENDUNGEN DAVON
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 05/11/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 26/11/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 08/10/2025
- Unitary Effect Registration Date:
- 26/11/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 05/01/2018
- Grant date:
- 08/10/2025
- EP Publication Date:
- 13/11/2019
- PCT Publication Date:
- 12/07/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/10/2025
- EP B1 Publication Date:
- 08/10/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 05/01/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/11/2025
- Name:
- Iovance Biotherapeutics, Inc.
- Address:
- 825 Industrial Road Suite 100, San Carlos, CA 94070, United States (US)
History of Owners
- From:
- 01/10/2025
- To:
- 21/11/2025
- Name:
- Iovance Biotherapeutics, Inc.
- Address:
- 825 Industrial Road Suite 400, San Carlos, CA 94070, United States (US)
Inventor
1
- Name:
- RITTHIPICHAI, Krit
- Address:
- United States (US)
2
- Name:
- LOTZE, Michael, T.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201762443519 P
- Priority Date:
- 06/01/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762466921 P
- Priority Date:
- 03/03/2017
- Priority Country:
- United States (US)
3
- Priority Number:
- 201762504385 P
- Priority Date:
- 10/05/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/00; C12N 5/0783;
Publication
European Patent Bulletin
1
- Issue number:
- 202541
- Publication date:
- 08/10/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202552
- Publication date:
- 24/12/2025
- Description:
- Change of owner's name or address
3
- Issue number:
- 202550
- Publication date:
- 10/12/2025
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202601
- Publication date:
- 31/12/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|